“Please attend this conference.  It contains all the information you need to refine or define your practices!” – 2009  Attendee, Lisa DeTora, Publication Manager, Novartis Vaccines and Diagnostics

For the 6^th straight year, this conference discusses the “nuts and bolts” of strategic publication planning.  Transparency has never been more demanding and this conference continues to keep all publication planning teams up to speed on how their policies align with the changing external environment.  The pharmaceutical industry continues to shift and become more difficult to operate in with new regulations and laws banning specific activities from manufacturing organizations.  Attend this conference to understand how these changes impact your publication planning initiatives.

Key themes include:

• Demands of increased transparency
• Journals refusing manuscripts because of ‘funding’ from industry
• More defined lines clarifying conflicts of interest
• Integrating health outcomes into pub planning
• Differences in FDA/EU guidelines for approvals
• Impact of Health Care Reform

2009 Attendee Profile

Hear what some of our previous attendees had to say:

“Very informative, high quality conference that helps all players in Pub Planning to keep abreast of industry trends and new regulations/ guidelines.” 
– Valerie Philippon, Director of Publications, Vertex

“The workshops with real life scenarios were a great way to share and validate solutions.”
– Sejal Vora, Senior Manager, Jansenn Alzheimer Immunotherapy

“Great content!  Very up-to-date and quality speakers!”
– Diane Nelson, Associate Director, Med Affairs, Medicis

Sponsors/Exhibitors:

	EPI-Q is a scientific agency and consultancy dedicated to providing novel research, strategic direction, and communication solutions that uncover the true value of healthcare innovation.  EPI-Q creates opportunities to build and enhance platforms for growth.  Since its inception in 1994, EPI-Q has assisted Fortune 100 biopharmaceutical and medical device firms facilitate market access and optimize pricing and reimbursement by demonstrating the clinical and economic benefits of medical therapies and technologies. EPI-Q is unique with its staff of resident experts who have been front line healthcare practitioners and decision makers — treating and educating patients, implementing practice guidelines, executing quality improvement initiatives, and assuring access to evidence-based care. With its global network spanning the payer, provider, policy and academic communities, EPI-Q can tailor strategies, execute research, and develop programs in the most effective, efficient and customized way.

For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.